Organisation: Pharmacyclics

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

AstraZeneca chases $5bn Acerta Pharma deal for better cancer drug portfolio

AstraZeneca said yesterday it was in talks that might lead to the acquisition of privately held biotech firm Acerta Pharma, a potential $5bn-plus (€4.54bn) deal designed to build up its cancer drug portfolio.

Tue, 15 Dec, 2015

Horizon to buy rival pharmaceutical for €1bn

Dublin-headquartered Horizon pharmaceutical has agreed to buy Hyperion Therapeutics for $1.1bn (€1bn) to gain drugs to treat rare metabolic diseases, adding to this year’s surge in pharmaceutical- industry takeovers.

Tue, 31 Mar, 2015

Elan makes new board appointment

ELAN has announced the appointment of William Rohn to the company’s board of directors.

Mon, 29 May, 2006

Organisation: Pharmacyclics

AstraZeneca chases $5bn Acerta Pharma deal for better cancer drug portfolio

Horizon to buy rival pharmaceutical for €1bn

Elan makes new board appointment

Latest

Mick Clifford

Organisation: Pharmacyclics

AstraZeneca chases $5bn Acerta Pharma deal for better cancer drug portfolio

Horizon to buy rival pharmaceutical for €1bn

Elan makes new board appointment

Latest

Mick Clifford

Most Read